Download PDF
PiD - Psychotherapie im Dialog 2024; 25(04): 57-62
DOI: 10.1055/a-2249-8252
Aus der Praxis

Das Reizdarmsyndrom: kognitiv-behaviorale Faktoren und Interventionen

Lisa Stöckner‡
,
Ina Külpmann‡
,
Adriane Icenhour
,
Sigrid Elsenbruch
› Further Information
Also available at
    Permissions and Reprints

Aus psychiatrisch-psychosomatischer Perspektive kann das Reizdarmsyndrom als eine somatische Belastungsstörung mit Schwerpunkt der Symptomatik im gastrointestinalen Bereich begriffen werden. Dieser Beitrag gibt Einblick in aktuelles Wissen über psychologische Faktoren bei der Entstehung und Aufrechterhaltung der Symptomatik und leitet daraus Interventionsmöglichkeiten der kognitiven Verhaltenstherapie ab.



Publication History

Article published online:
19 November 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Layer P, Andresen V, Allescher H. et al. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Z Gastroenterol 2021; 59: 1323-1415
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Oka P, Parr H, Barberio B. et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5: 908-917
    CrossrefPubMedGoogle Scholar
  • 3 Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 2000; 85: 317-332
    CrossrefPubMedGoogle Scholar
  • 4 Hauser G, Pletikosic S, Tkalcic M. Cognitive behavioral approach to understanding irritable bowel syndrome. World J Gastroenterol 2014; 20: 6744-6758
    CrossrefPubMedGoogle Scholar
  • 5 Dindo L, Lackner J. Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2017; 15: 1500-1503
    CrossrefPubMedGoogle Scholar
  • 6 Windgassen S, Moss-Morris R, Chilcot J. et al. The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome. Br J Health Psychol 2017; 22: 701-736
    CrossrefPubMedGoogle Scholar
  • 7 Tanaka Y, Kanazawa M, Fukudo S. et al. Biopsychosocial Model of Irritable Bowel Syndrome. J Neurogastroenterol Motil 2011; 17: 131-139
    CrossrefPubMedGoogle Scholar
  • 8 David L, Stanculete MF, Bolba AR. et al. Coping Strategies and Irritable Bowel Syndrome: A Systematic Review. J Gastrointestin Liver Dis 2021; 30: 485-494
    CrossrefPubMedGoogle Scholar
  • 9 Keefer L, Ballou SK, Drossman DA. et al. A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction. Gastroenterol 2022; 162: 300-315
    CrossrefPubMedGoogle Scholar
  • 10 Porcelli P, De Carne M, Leandro G. Alexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome. Compr Psychiatry 2014; 55: 1647-1653
    CrossrefPubMedGoogle Scholar
  • 11 Henrich JF, Martin M. Altered attentional control linked to catastrophizing in patients with irritable bowel syndrome. Br J Health Psychol 2018; 23: 612-629
    CrossrefPubMedGoogle Scholar
  • 12 Aulenkamp J, Steinmüller K, Icenhour A. et al. From gut feeling to visceral pain: Effects of negative expectations in the context of the gut–brain axis. Schmerz 2022; 36: 182-188
    PubMedGoogle Scholar
  • 13 Craske MG, Wolitzky-Taylor KB, Labus J. et al. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther 2011; 49: 413-421
    CrossrefPubMedGoogle Scholar
  • 14 Labrenz F, Woud ML, Elsenbruch S. et al. The Good, the Bad, and the Ugly—Chances, Challenges, and Clinical Implications of Avoidance Research in Psychosomatic Medicine. Front Psychiatry 2022; 13
    PubMedGoogle Scholar
  • 15 Labanski A, Langhorst J, Engler H. et al. Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: A transdisciplinary challenge. Psychoneuroendocrinol 2020; 111
    PubMedGoogle Scholar
  • 16 Hetterich L, Stengel A. Psychotherapeutic Interventions in Irritable Bowel Syndrome. Front Psychiatry 2020; 11
    PubMedGoogle Scholar
  • 17 Weibert E, Stengel A. The Role of Psychotherapy in the Treatment of Irritable Bowel Syndrome. Psychother Psychosom Med Psychol 2019; 69: 360-371
    PubMedGoogle Scholar
  • 18 Windgassen S, Moss-Morris R, Goldsmith K. et al. Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: The importance of gastrointestinal related cognitions, behaviours and general anxiety. J Psychosom Res 2019; 118: 73-82
    CrossrefPubMedGoogle Scholar
  • 19 Gilliam WP, Schumann ME, Cunningham JL. et al. Pain catastrophizing as a treatment process variable in cognitive behavioural therapy for adults with chronic pain. Eur J Pain 2021; 25: 339-347
    CrossrefPubMedGoogle Scholar
  • 20 Ljótsson B, Hesser H, Andersson E. et al. Mechanisms of Change in an Exposure-Based Treatment for Irritable Bowel Syndrome. J Consult Clin Psychol 2013; 81: 1113-1126
    CrossrefPubMedGoogle Scholar
  • 21 Drossman DA, Ruddy J. Improving Patient-Provider Relationships to Improve Health Care. Clin Gastroenterol Hepatol 2020; 18: 1417-1426
    CrossrefPubMedGoogle Scholar
  • 22 Schmid J, Theysohn N, Gaß F. et al. Neural mechanisms mediating positive and negative treatment expectations in visceral pain: A functional magnetic resonance imaging study on placebo and nocebo effects in healthy volunteers. Pain 2013; 154: 2372-2380
    CrossrefPubMedGoogle Scholar
  • 23 Lu HC, Hsieh JC, Lu CL. et al. Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: a 3T-fMRI study. Pain 2010; 148: 75-83
    CrossrefPubMedGoogle Scholar
  • 24 Bosman M, Elsenbruch S, Corsetti M. et al. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021; 6: 459-473
    CrossrefPubMedGoogle Scholar
  • 25 Elsenbruch S, Enck P. Placebo effects and their determinants in gastrointestinal disorders. Nat Rev Gastroenterol Hepatol 2015; 12: 472-485
    CrossrefPubMedGoogle Scholar
  • 26 Kaptchuk TJ, Kelley JM, Conboy LA. et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003
    CrossrefPubMedGoogle Scholar
  • 27 Lembo A, Kelley JM, Nee J. et al. Open-label placebo vs double-blind placebo for irritable bowel syndrome: A randomized clinical trial. Pain 2021; 162: 2428-2435
    CrossrefPubMedGoogle Scholar
  • 28 Nurko S, Saps M, Kossowsky J. et al. Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial. JAMA Pediatr 2022; 176: 349-356
    CrossrefPubMedGoogle Scholar
  • 29 Elsenbruch S, Labrenz F. Nocebo Effects and Experimental Models in Visceral Pain. Int Rev Neurobiol 2018; 138: 285-306
    CrossrefPubMedGoogle Scholar
  • 30 Roderigo T, Benson S, Schöls M. et al. Effects of acute psychological stress on placebo and nocebo responses in a clinically relevant model of visceroception. Pain 2017; 158: 1489-1498
    CrossrefPubMedGoogle Scholar